In vitro and in vivo synergistic activity of colistin, rifampin, and amikacin against a multiresistant Pseudomonas aeruginosa isolate [3]

Clinical Microbiology and Infection

Volumn 6, Issue 12, 2000, Pages 690-691

  Tascini, C ^a   Ferranti, S ^a   Messina, F ^a   Menichetti, F ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; COLISTIN; FOSFOMYCIN; METHYLPREDNISOLONE; RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CALCULATION; CASE REPORT; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; HEMOLYTIC ANEMIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0034583930     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2000.00169.x     Document Type: Letter

References (9)

1. Rifampin: Spectrum of antibacterial activity
2. In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of A. baumannii
3. Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against A. baumannii
4. Performance standards for antimicrobial susceptibility testing
5. Comparative in vitro antimicrobial susceptibilities of nosocomial combinations
6. Methodology for the serum bactericidal test
7. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant P. aeruginosa and A. baumannii
8. Pseudomonas aeruginosa isolated from corneal ulcer: Susceptibility to antimicrobial agents tested alone or in combination
9. Polycations as outer membrane-disorganizing agents